Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy

Cytotherapy(2021)10.1016/j.jcyt.2021.05.010Source: DataRank Database

Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy is a research paper published in Cytotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (29)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Ping Chen ORCID,Molly Javier Uyeda ORCID,Brandon Cieniewicz ORCID,Ece Canan Sayitoğlu ORCID,Benjamin Thomas ORCID

Live enrichment

PubMed:34404616

Stanford Maternal and Child Health Research Institute

Grant: 2T32DK098132-06A1

Training in Pediatric Nonmalignant Hematology and Stem Cell Biology

Stanford Maternal and Child Health Research Institute

Grant: S10OD018220

NIH

Grant: 2P01CA049605

NCI NIH HHS

Grant: P01 CA049605

NIDDK NIH HHS

Grant: P30 DK116074

NIDDK NIH HHS

Grant: T32 DK098132

greenLicense: Elsevier TDM

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S1465324921006903

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8546780

publisherhttps://api.elsevier.com/content/article/PII:S1465324921006903?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1465324921006903?httpAccept=text/plain

https://doi.org/10.1016/j.jcyt.2021.05.010

Fields of Study

Medicine0301 basic medicine03 medical and health sciences0302 clinical medicineCD4-Positive T-LymphocytesGraft vs Host DiseaseGraft vs Leukemia EffectHematopoietic Stem Cell TransplantationHumansImmunotherapyT-Lymphocytes, Regulatory

MeSH Terms

CD4-Positive T-LymphocytesGraft vs Host DiseaseGraft vs Leukemia EffectHematopoietic Stem Cell TransplantationHumansImmunotherapyT-Lymphocytes, Regulatory

Keywords

CD4-Positive T-LymphocytesHematopoietic Stem Cell TransplantationGraft vs Host DiseaseHumansGraft vs Leukemia EffectImmunotherapyT-Lymphocytes, RegulatoryIL-10 lentiviral vectoradoptive T-cell therapygraft-versus-host diseasetype 1 regulatory T cells

Sustainable Development Goals

SDG 3: 3. Good health